Pharma-Bio Serv, Inc. (PBSV) news stock charts
Pharma-Bio Serv, Inc. (PBSV/PBSV.OB) Investment Summary:
Pharma-Bio Serv, Inc. provides validation and regulatory compliance consulting services. The company assists its clients in complying with government regulations by offering a range of consulting services in the areas relating to compliance with the regulations of Food and Drug Administration, as well as matters relating to the introduction of new pharmaceutical products, project management, technology transfers, validation, and training services. It also provides technical consulting services, including regulatory compliance, validation, technology transfer, engineering, safety and environmental, training, project management, and process support. Pharma-Bio Serv markets its services to phar...PHARMA-BIO SERV INC (PBSV:OTC Bulletin Board Market)
Snapshot of PHARMA-BIO SERV INC (PBSV)
|
OPEN
$0.28
|
PREVIOUS CLOSE
$0.25
|
|
|
DAY HIGH
$0.28
|
DAY LOW
$0.25
|
|
|
52 WEEK HIGH
08/26/09 - $0.65
|
52 WEEK LOW
01/28/10 - $0.16
|
|
|
MARKET CAP
5.2M
|
AVERAGE VOLUME 10 D
2.4K
|
|
|
EPS TTM
$0.02
|
SHARES OUTSTANDING
20.8M
|
|
|
PBSV Does Not Pay Dividends
|
P/E TTM
15.6x
|
|
| K = Thousands M = Millions B = Billions | ||
Key developments for PHARMA-BIO SERV INC (PBSV)
Pharma-Bio Serv Inc. reported earnings results for the third quarter ended July 31, 2009. Net income for the quarter was $53,289, down $514,878 for the same quarter the previous year.
Pharma-Bio Serv Inc. reported earnings results for the second quarter ended April 30, 2009. For the quarter, the company reported net income of $267,951. In contrast, the company posted a net income of $345,184 for the same quarter in the previous year.
Pharma-Bio Serv Inc., Annual General Meeting, Aug 18, 2008, at 13:00 US Eastern Time. Location: Industrial Zone, Street No. 1, Lot No. 14, Higuillar Ward, Dorado, Puerto Rico, 00646, United States. Agenda: To consider election of five directors to serve until the 2009 Annual Meeting of Stockholders or until their successors are elected and qualified; to ratify the selection of Horwath Velez & Co. PSC as the company's independent certified public accountants for the fiscal year ending October 31, 2008; and to transaction of such other and further business as may properly come before the meeting or any, adjournments or postponements of the meeting .
Pharma-Bio Serv, Inc. financial resources
PBSV Competitors
| Company | Last | Change | |
| No competitor information is available for PBSV. | |||
| Market data is delayed at least 15 minutes. | |||
Industry Analysis
| Valuation | PBSV | Industry Range |
| Price/Earnings | 10.4x |
|
| Price/Sales | 0.5x |
|
| Price/Book | 1.1x |
|
| Price/Cash Flow | 9.7x |
|
| TEV/Sales | 0.3x |
|
|
PBSV |
||
PBSV transactions
| Type Date |
Target | |
| No transactions in the last 6 months. | ||
More Recent Financial News About Pharma-Bio Serv, Inc.
PHARMA-BIO SERV, INC. Files SEC form 8-K, Termination of a Material Definitive Agreement, Change in Directors or Prin
Read article
PHARMA-BIO SERV, INC. Files SEC form 8-K, Change in Directors or Principal Officers, Financial Statements and Exhibit
Read article
PHARMA-BIO SERV, INC. Files SEC form 10-Q, Quarterly Report
Read article
PHARMA-BIO SERV, INC. Files SEC form 8-K, Change in Directors or Principal Officers, Financial Statements and Exhibit
Read article
PHARMA-BIO SERV, INC. Files SEC form 8-K, Material Modification to Rights of Security Holders, Financial Statements a
Read article